Brief report: Clinical experiences after emergency use of daratumumab monotherapy for relapsed or refractory multiple myeloma in real practice
- Authors
- Park, Sung-Soo; Eom, Hyeon-Seok; Kim, Jin Seok; Koh, Youngil; Choi, Chul Won; Lee, Je-Jung; Kim, Kihyun; Suh, Cheolwon; Lee, Jae Hoon; Min, Chang-Ki
- Issue Date
- 1월-2019
- Publisher
- OXFORD UNIV PRESS
- Keywords
- CD38; Daratumumab; relapsed; refractory; multiple myeloma
- Citation
- JAPANESE JOURNAL OF CLINICAL ONCOLOGY, v.49, no.1, pp.92 - 95
- Indexed
- SCIE
SCOPUS
- Journal Title
- JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 49
- Number
- 1
- Start Page
- 92
- End Page
- 95
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/68820
- DOI
- 10.1093/jjco/hyy177
- ISSN
- 0368-2811
- Abstract
- Despite the recently reported efficacy of daratumumab monotherapy for patients with relapsed or refractory multiple myeloma, outcomes in real practice following daratumumab monotherapy have yet to be investigated. A multi-center retrospective study of 16 Korean patients receiving daratumumab monotherapy for relapsed or refractory multiple myeloma was conducted. The overall response rate was 56.3%. Three patients with creatinine clearance <30 ml/min even achieved an overall response. The median progression-free survival was 2.7 months with 28.9% (95% CI, 9.0-52.8) of 6-month progression-free survival. All infusion-related reactions, including >= Grade 3 back pain (6.3%) and dyspnea (6.3%), were manageable. The most common hematologic and non-hematological adverse events were anemia (62.5%) and upper respiratory infection (43.8%). >= Grade 3 bacterial infectious adverse events were identified, including upper and lower respiratory infection (12.5% and 18.8%) and death following sepsis (6.3%). We observed acceptable outcomes of daratumumab monotherapy on relapsed or refractory multiple myeloma patients including even a few subjects with high comorbidity, despite relatively frequent infectious adverse events.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Graduate School > Department of Biomedical Sciences > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.